MERCK & CO., INC. et al v. UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES et al

  1. August 21, 2019

    Feds Look To DC Circ. To Revive Drug Pricing Rule

    The U.S. Department of Health and Human Services looked to the D.C. Circuit Wednesday hoping to overturn a federal judge's July decision vacating a federal regulation that would have mandated the disclosure of wholesale drug prices in television advertisements.

  2. July 10, 2019

    3 Takeaways From Nixing Of Drug Pricing Rule

    The day before it was scheduled to go into effect, a D.C. federal judge struck down a Trump administration rule requiring drug prices to be disclosed in TV ads, a new regulation that could have amped up U.S. Department of Health and Human Services' regulatory power.

  3. July 08, 2019

    Judge Nixes Rule Forcing Drug Prices In TV Ads

    A D.C. federal judge on Monday vacated a federal regulation mandating the disclosure of wholesale drug prices in television advertisements, a decision that came just the day before the controversial requirement was set to take effect.

  4. July 02, 2019

    Feds, Drugmakers Grilled Over Rule Mandating Prices In Ads

    A D.C. federal judge asked sharp questions Tuesday as to whether the government can require manufacturers' drug prices in TV ads, as several drugmakers argued that a new rule mandating the disclosures would mislead consumers and step outside the feds' authority.

  5. June 18, 2019

    Swift Ruling Vowed On Rule Requiring Drug Prices In TV Ads

    A D.C. federal judge is expected to decide in less than three weeks — a blazingly quick turnaround — on whether to block a new U.S. Department of Health and Human Services rule requiring drug prices in TV ads as the regulation's effective date looms.

  6. June 14, 2019

    Pharma Cos. Sue HHS Over Putting Drug Prices In Ads

    Merck & Co. Inc., Eli Lilly & Co. and Amgen Inc. on Friday sued the U.S. Department of Health and Human Services over a new rule requiring drugmakers to put the wholesale price of medications in ads, saying the requirement will mislead consumers about how much they'll actually have to pay.